Global In-vitro Colorectal Cancer Screening Tests Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In-Vitro Colorectal Cancer Screening Tests Revenue
1.4 Market Analysis by Type
1.4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biomarker Tests
1.4.3 Fecal Occult Blood Tests
1.4.4 CRC DNA Screening Tests
1.5 Market by Application
1.5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Share by Application: 2020 VS 2026
1.5.2 Hospital and Clinics
1.5.3 Ambulatory
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 In-Vitro Colorectal Cancer Screening Tests Market Perspective (2015-2026)
2.2 In-Vitro Colorectal Cancer Screening Tests Growth Trends by Regions
2.2.1 In-Vitro Colorectal Cancer Screening Tests Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In-Vitro Colorectal Cancer Screening Tests Historic Market Share by Regions (2015-2020)
2.2.3 In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 In-Vitro Colorectal Cancer Screening Tests Market Growth Strategy
2.3.6 Primary Interviews with Key In-Vitro Colorectal Cancer Screening Tests Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Market Size
3.1.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue (2015-2020)
3.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Players (2015-2020)
3.1.3 Global In-Vitro Colorectal Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio
3.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by In-Vitro Colorectal Cancer Screening Tests Revenue in 2019
3.3 In-Vitro Colorectal Cancer Screening Tests Key Players Head office and Area Served
3.4 Key Players In-Vitro Colorectal Cancer Screening Tests Product Solution and Service
3.5 Date of Enter into In-Vitro Colorectal Cancer Screening Tests Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Type (2015-2020)
4.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Type (2021-2026)
5 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Application (2015-2026)
5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020)
5.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size (2015-2020)
6.2 In-Vitro Colorectal Cancer Screening Tests Key Players in North America (2019-2020)
6.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020)
6.4 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020)
7 Europe
7.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size (2015-2020)
7.2 In-Vitro Colorectal Cancer Screening Tests Key Players in Europe (2019-2020)
7.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020)
7.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020)
8 Australia
8.1 Australia In-Vitro Colorectal Cancer Screening Tests Market Size (2015-2020)
8.2 In-Vitro Colorectal Cancer Screening Tests Key Players in Australia (2019-2020)
8.3 Australia In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020)
8.4 Australia In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020)
9 Japan
9.1 Japan In-Vitro Colorectal Cancer Screening Tests Market Size (2015-2020)
9.2 In-Vitro Colorectal Cancer Screening Tests Key Players in Japan (2019-2020)
9.3 Japan In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020)
9.4 Japan In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020)
10 Key Players Profiles
10.1 Alere(Abbott)
10.1.1 Alere(Abbott) Company Details
10.1.2 Alere(Abbott) Business Overview and Its Total Revenue
10.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Introduction
10.1.4 Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020))
10.1.5 Alere(Abbott) Recent Development
10.2 Beckman Coulter
10.2.1 Beckman Coulter Company Details
10.2.2 Beckman Coulter Business Overview and Its Total Revenue
10.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Introduction
10.2.4 Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.2.5 Beckman Coulter Recent Development
10.3 Siemens Healthcare
10.3.1 Siemens Healthcare Company Details
10.3.2 Siemens Healthcare Business Overview and Its Total Revenue
10.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Introduction
10.3.4 Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.3.5 Siemens Healthcare Recent Development
10.4 Eiken Chemical
10.4.1 Eiken Chemical Company Details
10.4.2 Eiken Chemical Business Overview and Its Total Revenue
10.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Introduction
10.4.4 Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.4.5 Eiken Chemical Recent Development
10.5 Hitachi Chemical (Kyowa Medex)
10.5.1 Hitachi Chemical (Kyowa Medex) Company Details
10.5.2 Hitachi Chemical (Kyowa Medex) Business Overview and Its Total Revenue
10.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Introduction
10.5.4 Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.5.5 Hitachi Chemical (Kyowa Medex) Recent Development
10.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
10.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
10.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview and Its Total Revenue
10.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Introduction
10.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
10.7 Sysmex
10.7.1 Sysmex Company Details
10.7.2 Sysmex Business Overview and Its Total Revenue
10.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Introduction
10.7.4 Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.7.5 Sysmex Recent Development
10.8 QIAGEN
10.8.1 QIAGEN Company Details
10.8.2 QIAGEN Business Overview and Its Total Revenue
10.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Introduction
10.8.4 QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.8.5 QIAGEN Recent Development
10.9 R-Biopharm
10.9.1 R-Biopharm Company Details
10.9.2 R-Biopharm Business Overview and Its Total Revenue
10.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Introduction
10.9.4 R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.9.5 R-Biopharm Recent Development
10.10 Immunostics
10.10.1 Immunostics Company Details
10.10.2 Immunostics Business Overview and Its Total Revenue
10.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Introduction
10.10.4 Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
10.10.5 Immunostics Recent Development
11 Analyst's Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of TablesTable 1. In-Vitro Colorectal Cancer Screening Tests Key Market Segments
Table 2. Key Players Covered: Ranking by In-Vitro Colorectal Cancer Screening Tests Revenue
Table 3. Ranking of Global Top In-Vitro Colorectal Cancer Screening Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biomarker Tests
Table 6. Key Players of Fecal Occult Blood Tests
Table 7. Key Players of CRC DNA Screening Tests
Table 8. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Regions (2015-2020)
Table 12. Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. In-Vitro Colorectal Cancer Screening Tests Market Growth Strategy
Table 18. Main Points Interviewed from Key In-Vitro Colorectal Cancer Screening Tests Players
Table 19. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Players (2015-2020) (Million US$)
Table 20. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Players (2015-2020)
Table 21. Global Top In-Vitro Colorectal Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2019)
Table 22. Global In-Vitro Colorectal Cancer Screening Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players In-Vitro Colorectal Cancer Screening Tests Product Solution and Service
Table 25. Date of Enter into In-Vitro Colorectal Cancer Screening Tests Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 28. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2015-2020)
Table 29. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2021-2026)
Table 30. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2015-2020)
Table 31. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 32. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2026)
Table 33. North America Key Players In-Vitro Colorectal Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 34. North America Key Players In-Vitro Colorectal Cancer Screening Tests Market Share (2019-2020)
Table 35. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 36. North America In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2015-2020)
Table 37. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 38. North America In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2015-2020)
Table 39. Europe Key Players In-Vitro Colorectal Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players In-Vitro Colorectal Cancer Screening Tests Market Share (2019-2020)
Table 41. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 42. Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2015-2020)
Table 43. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 44. Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2015-2020)
Table 45. Australia Key Players In-Vitro Colorectal Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 46. Australia Key Players In-Vitro Colorectal Cancer Screening Tests Market Share (2019-2020)
Table 47. Australia In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 48. Australia In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2015-2020)
Table 49. Australia In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 50. Australia In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2015-2020)
Table 51. Japan Key Players In-Vitro Colorectal Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players In-Vitro Colorectal Cancer Screening Tests Market Share (2019-2020)
Table 53. Japan In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 54. Japan In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2015-2020)
Table 55. Japan In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 56. Japan In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2015-2020)
Table 57. Alere(Abbott) Company Details
Table 58. Alere(Abbott) Business Overview
Table 59. Alere(Abbott) Product
Table 60. Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 61. Alere(Abbott) Recent Development
Table 62. Beckman Coulter Company Details
Table 63. Beckman Coulter Business Overview
Table 64. Beckman Coulter Product
Table 65. Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 66. Beckman Coulter Recent Development
Table 67. Siemens Healthcare Company Details
Table 68. Siemens Healthcare Business Overview
Table 69. Siemens Healthcare Product
Table 70. Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 71. Siemens Healthcare Recent Development
Table 72. Eiken Chemical Company Details
Table 73. Eiken Chemical Business Overview
Table 74. Eiken Chemical Product
Table 75. Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 76. Eiken Chemical Recent Development
Table 77. Hitachi Chemical (Kyowa Medex) Company Details
Table 78. Hitachi Chemical (Kyowa Medex) Business Overview
Table 79. Hitachi Chemical (Kyowa Medex) Product
Table 80. Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 81. Hitachi Chemical (Kyowa Medex) Recent Development
Table 82. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
Table 83. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
Table 84. Clinical Genomics Pty Ltd (Quest Diagnostics) Product
Table 85. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 86. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
Table 87. Sysmex Company Details
Table 88. Sysmex Business Overview
Table 89. Sysmex Product
Table 90. Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 91. Sysmex Recent Development
Table 92. QIAGEN Business Overview
Table 93. QIAGEN Product
Table 94. QIAGEN Company Details
Table 95. QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 96. QIAGEN Recent Development
Table 97. R-Biopharm Company Details
Table 98. R-Biopharm Business Overview
Table 99. R-Biopharm Product
Table 100. R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 101. R-Biopharm Recent Development
Table 102. Immunostics Company Details
Table 103. Immunostics Business Overview
Table 104. Immunostics Product
Table 105. Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020) (Million US$)
Table 106. Immunostics Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of FiguresFigure 1. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Type: 2020 VS 2026
Figure 2. Biomarker Tests Features
Figure 3. Fecal Occult Blood Tests Features
Figure 4. CRC DNA Screening Tests Features
Figure 5. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Application: 2020 VS 2026
Figure 6. Hospital and Clinics Case Studies
Figure 7. Ambulatory Case Studies
Figure 8. Home Care Case Studies
Figure 9. In-Vitro Colorectal Cancer Screening Tests Report Years Considered
Figure 10. Global In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Regions: 2020 VS 2026
Figure 12. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Players in 2019
Figure 15. Global Top In-Vitro Colorectal Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2019
Figure 16. The Top 10 and 5 Players Market Share by In-Vitro Colorectal Cancer Screening Tests Revenue in 2019
Figure 17. North America In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Australia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Alere(Abbott) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Alere(Abbott) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 23. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Beckman Coulter Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 25. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Siemens Healthcare Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 27. Eiken Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eiken Chemical Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 29. Hitachi Chemical (Kyowa Medex) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 31. Clinical Genomics Pty Ltd (Quest Diagnostics) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 33. Sysmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sysmex Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 35. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. QIAGEN Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 37. R-Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. R-Biopharm Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 39. Immunostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Immunostics Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed